1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Gabriella Miller Kids First Pediatric Research Program (Kids First) Cloud Credits Pilot is sponsored by National Institutes of Health (NIH). This pilot program offers cloud credits to researchers to conduct cloud-based analyses using Kids First data. The program aims to reduce barriers to using a web-based platform for analyzing Kids First and non-Kids First data in a single cloud workspace.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Gabriella Miller Kids First Pediatric Research Program (Kids First) | NIH Common Fund Gabriella Miller Kids First Pediatric Research (Kids First) Gabriella Miller Kids First Pediatric Research (Kids First) NIH Common Fund’s Gabriella Miller Kids First Pediatric Research Program The goal of the Gabriella Miller Kids First Pediatric Research Program (Kids First) is to help researchers uncover new insights into the biology of childhood cancer and structural birth defects, including the discovery of shared genetic pathways between these disorders.
The goal of the Gabriella Miller Kids First Pediatric Research Program (Kids First) is to help researchers uncover new insights into the biology of childhood cancer and congenital anomalies, including the discovery of shared genetic pathways between these disorders. Children with birth defects have an increased risk of developing childhood cancer.
This suggests there are shared genetic pathways underlying some types of childhood cancer and congenital anomalies. The Kids First program is in its second iteration, Kids First 2. 0, which continues to advance the groundwork laid in the program's first ten years.
Kids First is achieving this goal through two initiatives: 1) identifying children with childhood cancer and structural birth defects and their families for whole genome sequencing performed by the Kids First sequencing centers 2) developing the Gabriella Miller Kids First Data Resource, a large-scale database of clinical and genetic data from patients with childhood cancers and congenital anomalies and their families.
Analyzing genetic sequence data from children with childhood cancer and congenital anomalies together may lead to the discovery of new genetic pathways.
Clinical and genetic data from 36 of the Kids First projects are publicly available through the Gabriella Miller Kids First Data Resource Portal , a cloud-based platform made up of tools to foster analyses and collaborations between childhood cancer and congenital anomalies research communities. Kids First is enabling new findings in birth defects and childhood cancers.
For an overview of the Kids First Program watch the video below: Read the Gabriella Miller Kids First Research Act bill . NIH resources on Birth Defects: Trans-NIH Structural Birth Defects Working Group NIH resources on Childhood Cancers Cancer Facts and Figures from the American Cancer Society. Kids First has over 36 Pediatric Cancer and Congenital Anomaly Datasets.
Check it out at the Kids First Data Resource Portal ! Kids First Cloud Credits Pilot is Open to All Researchers! Cloud Credits are open and available to all researchers and sponsored by NIH.
These credits enable researchers to conduct cloud-based analyses accessing Kids First data and utilizing the tools available through the Kids First Data Resource Center . The Cloud Credits program aims to lower barriers for using a web-based platform, building and sharing workflows, and analyzing Kids First and non-Kids First data in one cloud workspace.
If you would like to participate in the Kids First Cloud Credits Pilot, please read and follow the instructions described in the pilot announcement. Requests are submitted and reviewed on a rolling basis for quick access to cloud credits. If you have any questions, please contact [email protected] .
Learn more about the Kids First Cloud Credits Pilot Program . The Gabriella Miller Kids First Data Resource Through its Data Resource Center and NIH X01 grant mechanism, Kids First supports data generation and data sharing in the cloud.
To date, the program has supported the public release of data from 37 projects and made available nearly 30,000 genomes, representing structural birth defects and childhood cancer patients and families through the Kids First Data Resource Portal . This page last reviewed on
According to the current listing, eligibility includes: Open to all researchers. Confirm the full requirements in the official notice before applying.
Gabriella Miller Kids First Pediatric Research Program (Kids First) Cloud Credits Pilot is funded by National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
PA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read articlePA-27-034, PA-27-035 and PA-27-036 replace the institute-specific R25 announcements that research education programs have been built around for a decade. NCI, NIDA and NIGMS have already expired theirs early. Here is what the consolidation actually changes: an 8% indirect cost ceiling, a US-citizens-and-permanent-residents participant rule, a cooperative agreement variant that only exists on one of the three, and no clinical-trial-allowed companion anywhere.
Read article